We report 7 cases which can be regarded as a syringotropic melanoma-a unique presentation of melanoma defined as melanoma spreading within the eccrine apparatus into the reticular dermis and/or subcutaneous tissue deeper than any (if present) associated invasive melanoma. Six patients were females, and 1 was a male. Their ages ranged from 32 to 85 years old (average 63). The lesions showed a wide site distribution, occurring on the extremities (4), trunk (2), and head and neck (1). Five melanomas were superficial spreading type; 1 was acral lentiginous type; 1 was unclassified. Four lesions (57%) invaded from within eccrine apparatus at a depth and anatomical level greater than that of an adjacent conventional invasive melanoma arising from the surface epidermis. In 1 lesion, which presented clinically as a pigmented macule, deep dermal syringocentric invasive tumor was the only site of invasion and tumorigenic growth. Thus, this variant of melanoma carries a significant risk of syringocentric deep dermal invasion, which may be unsuspected clinically but must be detected on histological examination to provide the most accurate prognosis and staging information.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/DAD.0b013e318227c90d | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Harnessing the eccrine sweat glands for the management of interdialytic weight gain - a pilot study.
Ren Fail
December 2024
Department of Cardiology, Rambam Health Care Campus and the Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Hemodialysis patients are susceptible to excess volume accumulation, particularly over the 2-day interval (long interdialytic gap), resulting in higher interdialytic weight gain (IDWG). We thought to determine whether a novel device designed to enhance fluid and salt loss by activating the eccrine sweat glands can mitigate IDWG. Patients eligible for the study were undergoing regular hemodialysis for ≥3 months, without residual renal function, and with IDWG (as a percentage of IDWG/dry body weight) ≥2.
View Article and Find Full Text PDFPretreatment of microneedles enhances passive transdermal administration of pilocarpine and pilocarpine-induced sweat production in humans.
Int J Pharm
September 2024
CosMED Pharmaceutical Co. Ltd., Kyoto, Japan.
The development of an effective transdermal drug delivery protocol to eccrine sweat glands is important for the advancement of research on the human sweating response. We investigated whether microneedle treatment prior to the application of pilocarpine, a hydrophilic and sudorific agent that does not induce sweating due to a limited percutaneous passive diffusion by skin application alone, augments sweat production. We applied three microneedle arrays to forearm skin sites simultaneously (n = 20).
View Article and Find Full Text PDFPericanalicular eccrine hidrocystoma of the upper eyelid in a child.
BMJ Case Rep
October 2023
Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Article Synopsis
- - A child was diagnosed with a rare type of skin cyst called pericanalicular eccrine hidrocystoma located on the upper eyelid.
- - The child underwent surgical removal of the cyst along with repair of the affected canalicular area.
- - The surgery was successful, leading to a positive outcome for the child.
Transcriptional repressor GATA binding 1 (TRPS1) immunoexpression in normal skin tissues and various cutaneous tumors.
J Cutan Pathol
November 2023
Department of Pathology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Article Synopsis
- TRPS1, a transcription factor linked to breast and liver cancer, was analyzed for its expression in normal skin and various skin tumors.
- In normal skin, TRPS1 was absent in the epidermis but present in other skin structures like hair follicles and sebaceous glands.
- TRPS1 positivity varied across different cutaneous tumors, being particularly high in cases like extramammary Paget disease and metastatic breast cancer, while absent in several common skin cancers like melanoma and basal cell carcinoma.
Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases.
BMC Ophthalmol
January 2022
Centre of Eye Diseases, Vilnius University Hospital Santaros Klinikos, Santariskiu 2, LT-08661, Vilnius, Lithuania.
Background: Acquired nasolacrimal duct obstruction is a blockage of the lacrimal outflow system usually caused by local nonspecific inflammation of the lacrimal sac and the nasolacrimal duct. However, cases exist where the primary nasolacrimal system obstruction is caused by malignancies. Our aim was to investigate lacrimal sac pathologies in patients with acquired nasolacrimal duct obstruction and compare their clinical manifestations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!